Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Warr

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 1, 1995
A randomized trial of the effects of pharmacist intervention on the cost of antiemetic therapy with ondansetronG Dranitsaris, D Warr, A Puodziunas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1990
Phase I/II trial of granisetron: a novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomitingM Addelman, C Erlichman, S Fine, et al.
Breast Cancer Research and Treatment|January 1, 1994
Phase II trial of 5-fluorouracil and folinic acid in the treatment of advanced breast cancerS Fine, C Erlichman, L Kaizer, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 1, 1994
Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancerD Osoba, B Zee, J Pater, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 1, 1994
Inconsistency of prognostic factors for post-chemotherapy nausea and vomitingJ Pater, L Slamet, B Zee, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1997
Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials GroupD Osoba, B Zee, D Warr, et al.
Oncology|June 1, 1996
Quality of life studies in chemotherapy-induced emesisD Osoba, B Zee, D Warr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials GroupD Osoba, B Zee, J Pater, et al.
The Journal of Urology|August 1, 1991
Adult paratesticular sarcomas: a review of 21 casesC N Catton, B J Cummings, V Fornasier, et al.
Journal of Pain and Symptom Management|October 1, 1992
The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphineM Deschamps, P R Band, T G Hislop, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 1, 1995
A randomized trial of the effects of pharmacist intervention on the cost of antiemetic therapy with ondansetronG Dranitsaris, D Warr, A Puodziunas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1990
Phase I/II trial of granisetron: a novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomitingM Addelman, C Erlichman, S Fine, et al.
Breast Cancer Research and Treatment|January 1, 1994
Phase II trial of 5-fluorouracil and folinic acid in the treatment of advanced breast cancerS Fine, C Erlichman, L Kaizer, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 1, 1994
Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancerD Osoba, B Zee, J Pater, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 1, 1994
Inconsistency of prognostic factors for post-chemotherapy nausea and vomitingJ Pater, L Slamet, B Zee, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1997
Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials GroupD Osoba, B Zee, D Warr, et al.
Oncology|June 1, 1996
Quality of life studies in chemotherapy-induced emesisD Osoba, B Zee, D Warr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials GroupD Osoba, B Zee, J Pater, et al.
The Journal of Urology|August 1, 1991
Adult paratesticular sarcomas: a review of 21 casesC N Catton, B J Cummings, V Fornasier, et al.
Journal of Pain and Symptom Management|October 1, 1992
The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphineM Deschamps, P R Band, T G Hislop, et al.
Pageof 5